Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials

Chemotherapeutic agents used to treat cancer generally have narrow therapeutic indices along with potentially serious adverse toxicities. Many cancer drugs are at least partially excreted through the kidney and, thus, the availability of accurate data on safe and effective dosing of these drugs in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprangers, Ben, Perazella, Mark A., Lichtman, Stuart M., Rosner, Mitchell H., Jhaveri, Kenar D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458993/
https://www.ncbi.nlm.nih.gov/pubmed/36090489
http://dx.doi.org/10.1016/j.ekir.2022.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458993/
https://www.ncbi.nlm.nih.gov/pubmed/36090489
http://dx.doi.org/10.1016/j.ekir.2022.06.005

Ejemplares similares